CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Ingenol mebutate

Last Updated: May 26, 2014
Result type: Reports
Project Number: SF0382-000
Product Line: Reimbursement Review

Generic Name: Ingenol mebutate

Brand Name: Picato

Manufacturer: Leo Pharma Inc.

Therapeutic Area: Actinic keratosis

Indications: Actinic keratosis

Submission Type: Request For Advice

Project Status: Complete

Advice Issued: October 22, 2014